HYPERTHERMIA STUDIES WITH HUMAN-DERIVED CARCINOMA CELLS
人源癌细胞的热疗研究
基本信息
- 批准号:3185081
- 负责人:
- 金额:$ 10.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1986
- 资助国家:美国
- 起止时间:1986-08-01 至 1989-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Clinical results indicate that hyperthermia is most effective when used in
conjunction with other forms of established cancer therapy. The imminence
of Phase III clinical trials creates a need for a more comprehensive
understanding of heat effects in human tumors and its combined action with
radiation and drugs. Established biochemical assays and single cell
survival will serve as quantitative endpoints to investigate clinical
aspects of hyperthermia. Primary and established cultures of human breast,
lung and colon carcinoma cells will be used to evaluate fundamental aspects
of thermotolerance and thermochemotherapy. A primary goal is to establish
a methodology for signalling the development of thermotolerance in
heat-treated cells in freshly biopsied human tumors. Elevated levels of
heat shock proteins (HSP) and glutathione (GSH) will serve as the chemical
expression of heat resistance. Human umbilical vein endothelial cells will
be a model for vasculature in studying heat cytotoxicity and heat
resistance.
Human carcinoma cells from established lines will be used to study
quantitative aspects of thermochemotherapy. Exponential and plateau-phase
cultures will be exposed to acute and fractionated treatments of heat in
combination with x-rays or chemotherapeutic agents (i.E. L-PAM, Cis-DDP and
Tamoxifen). This simulates the response of cycling and slowly
proliferating cells. The efficacy of heat, x-rays or drugs in killing
thermotolerant cells will be established by thermotolerant ratios. Thiol
depletion will be used as a strategy to reverse the protective effects of
thermotolerance. Alteration of chemotherapeutic drug transport by
hyperthermia will be investigated using radiolabelled drugs.
Induction of thermotolerance in tumor-derived carcinoma cells and
interactive studies of heat with drugs and radiation should broaden our
basis for predicting the biological response of human tumors to clinical
hyperthermia.
临床结果表明,热疗是最有效的,当用于
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LAURIE A ROIZIN-TOWLE其他文献
LAURIE A ROIZIN-TOWLE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LAURIE A ROIZIN-TOWLE', 18)}}的其他基金
HYPERTHERMIA STUDIES WITH HUMAN-DERIVED CARCINOMA CELLS
人源癌细胞的热疗研究
- 批准号:
3185083 - 财政年份:1986
- 资助金额:
$ 10.9万 - 项目类别:
HYPERTHERMIA STUDIES WITH HUMAN-DERIVED CARCINOMA CELLS
人源癌细胞的热疗研究
- 批准号:
3185084 - 财政年份:1986
- 资助金额:
$ 10.9万 - 项目类别:
RADIO AND CHEMO SENSITIZATION DEPENDENCE ON OXYGEN
放射和化学增敏对氧气的依赖性
- 批准号:
3446480 - 财政年份:1983
- 资助金额:
$ 10.9万 - 项目类别:
相似海外基金
Molecular and Cellular Oncology Research Program
分子和细胞肿瘤学研究计划
- 批准号:
10712119 - 财政年份:2013
- 资助金额:
$ 10.9万 - 项目类别: